1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)


Table 5: 
Retreatments
No. of Aneurysms (%)PGLA-Coated Coils100% PGLA-Coated CoilsBare Platinum Coils
Overall17/82 (21%)8/42 (19%)7/80 (9%)
Originally treated with Neuroform stent or balloon remodeling4/171/81/7
Size (mm)
    0–1010/59 (17%)*6/34 (18%)3/57 (5%)*
    11–246/20 (30%)*2/7 (29%)2/19 (11%)*
    ≥251/3 (33%)*02/4 (50%)*
    >4 Neck411
    <4 Neck1406
  • Note:—PGLA indicates polyglycolic/polylactic acid.
  • * Percentages represent the % of aneurysms within a particular size category.